(Q37942690)

25 August 2017

1 reference

title

Insulin resistance and pathological brain ageing (English)

1 reference

25 August 2017

1 reference

1 reference

1

B Cholerton

1 reference

25 August 2017

2

L D Baker

1 reference

25 August 2017

S Craft

3

1 reference

25 August 2017

1 December 2011

1 reference

25 August 2017

1 reference

25 August 2017

28

1 reference

25 August 2017

12

1 reference

25 August 2017

1463-1475

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

25 August 2017

1 reference

Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin receptors are widely distributed in the central nervous system of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Identification of insulin in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Improving influence of insulin on cognitive functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin receptors and insulin action in the brain: review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Hypothalamic GLUT 4 expression: a glucose- and insulin-sensing mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Role of insulin and insulin receptor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Glucose treatment reduces memory deficits in young adult rats fed high-fat diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Cognitive function in an elderly population with persistent impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Basal and hyperinsulinemia-induced immunoreactive hypothalamic insulin changes in lean and genetically obese Zucker rats revealed by microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Role for neuronal insulin resistance in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin resistance, diabetes and cognitive function: consequences for preventative strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Predictors of cognitive decline and mortality of aged people over a 10-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Effect of age and glucoregulation on cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diabetes mellitus and cognitive performance in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Type 2 diabetes mellitus, cognitive impairment and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

The relationship between type 2 diabetes and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Plasma homocysteine levels and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Association of diabetes mellitus and dementia: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

The risk of dementia among persons with diabetes mellitus: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Metabolic links between diabetes and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Different patterns of cerebral injury in dementia with or without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Functional role of lipoprotein receptors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Plasma beta-amyloid (A beta) 40 concentration, lipid status and age in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Impact of plasma lipids and time on memory performance in healthy elderly without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Plasma cholesterol and risk for late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Hypertension and cerebrovascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Blood pressure and the risk for dementia: a double edged sword.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Two measures of insulin sensitivity provided similar information in a U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Nutrient-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Body mass index, dementia, and mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Central obesity and increased risk of dementia more than three decades later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Peroxisome proliferator-activated receptors in inflammation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Intracerebroventricular insulin enhances memory in a passive-avoidance task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Nasal drug delivery: new developments and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Central nervous system effects of intranasally administered insulin during euglycemia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Intranasal insulin improves memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Saturated fat, carbohydrate, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Fish, docosahexaenoic acid and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diet and neurocognition: review of evidence and methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diet and risk of dementia: Does fat matter?: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Food combination and Alzheimer disease risk: a protective diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Physical exercise alleviates debilities of normal aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Impact of age, sex, and exercise on brachial artery flow-mediated dilatation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Association between arterial elasticity, C-reactive protein and maximal oxygen consumption in well-trained cadets during three days extreme physical load: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Physical exercise, aging, and mild cognitive impairment: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Exercise and Alzheimer's disease biomarkers in cognitively normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Voluntary exercise and palatable high-fat diet both improve behavioural profile and stress responses in male rats exposed to early life stress: role of hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Usual vs. successful aging: some notes on experiential factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Physical activity over the life course and its association with cognitive performance and impairment in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

'Executive' functions and normal aging: selective impairment in conditional exclusion compared to abstraction and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Attention, working memory, and grammaticality judgment in typical young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

The relationship between episodic long-term memory and white matter integrity in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Cardiovascular fitness, cortical plasticity, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

The effects of exercise on cognition in older adults with and without cognitive decline: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Effects of aerobic exercise on mild cognitive impairment: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Walking and dementia in physically capable elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

A prospective study of physical activity and cognitive decline in elderly women: women who walk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Exercise, cognition, and the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Aerobic fitness reduces brain tissue loss in aging humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Aerobic exercise training increases brain volume in aging humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Exercise training increases size of hippocampus and improves memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Fitness effects on the cognitive function of older adults: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Structured exercise does not stabilize cognitive function in individuals with mild cognitive impairment residing in a structured living facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Walking the line: a randomised trial on the effects of a short term walking programme on cognition in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03464.X

10.1111/J.1464-5491.2011.03464.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21974744